Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Biologics Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of chronic disorders and rise in treatment rates
5.1.1.2. Growing demand and preference for minimally invasive procedures
5.1.1.3. Proliferation of advancements of bone grafting procedures
5.1.2. Restraints
5.1.2.1. High cost of treatment associated with biologics
5.1.3. Opportunities
5.1.3.1. Ongoing advancements in biomaterials improving the treatment of chronic disorders
5.1.3.2. Government funding to expand biologics research
5.1.4. Challenges
5.1.4.1. Issues related to product recalls
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Biologics Market, by Product
6.1. Introduction
6.2. Cellular Based Biologics
6.3. Gene Based Biologics
6.4. Monoclonal Antibodies
6.5.1. Diagnostic
6.5.2.1. Biochemical Analysis
6.5.2.2. Diagnostic Imaging
6.5.2. Therapeutic
6.5.3.1. Direct MAB Agents
6.5.3.2. Targeting MAB Agents
6.5. Recombinant Hormones or Proteins
6.6. Vaccines

7. Biologics Market, by Indication
7.1. Introduction
7.2. Autoimmune Diseases
7.3. Cancer
7.4. Infectious Diseases
7.5. Rare Diseases

8. Biologics Market, by End-user
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals

9. Americas Biologics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Biologics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Biologics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AbbVie Inc.
13.1.2. Amgen Inc.
13.1.3. AstraZeneca PLC
13.1.4. Bayer AG
13.1.5. Becton, Dickinson and Company
13.1.6. Biogen MA Inc.
13.1.7. BioPharm Laboratories, LLC
13.1.8. Bristol Myers Squibb Company
13.1.9. Catalent, Inc
13.1.10. Celltrion Healthcare Co., Ltd.
13.1.11. F. Hoffmann-La Roche Ltd.
13.1.12. Genentech, Inc.
13.1.13. Gilead Sciences, Inc.
13.1.14. GlaxoSmithKline PLC
13.1.15. Innovent Biologics, Inc.
13.1.16. Johnson & Johnson Services, Inc.
13.1.17. Merck KGaA
13.1.18. Novartis AG
13.1.19. Pfizer Inc.
13.1.20. Samsung Biologics Co.,Ltd.
13.1.21. Sanofi S.A.
13.1.22. Thermo Fisher Scientific Inc.
13.1.23. Vertex Pharmaceuticals, Inc.
13.1.24. WuXi Biologics Co., Ltd.
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. BIOLOGICS MARKET RESEARCH PROCESS
FIGURE 2. BIOLOGICS MARKET SIZE, 2023 VS 2030
FIGURE 3. BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOLOGICS MARKET DYNAMICS
FIGURE 7. BIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. BIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BIOLOGICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. BIOLOGICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. BIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. BIOLOGICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. BIOLOGICS MARKET SIZE, BY CELLULAR BASED BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BIOLOGICS MARKET SIZE, BY GENE BASED BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 10. BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 12. BIOLOGICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BIOLOGICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. BIOLOGICS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 16. BIOLOGICS MARKET SIZE, BY DIRECT MAB AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. BIOLOGICS MARKET SIZE, BY TARGETING MAB AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. BIOLOGICS MARKET SIZE, BY RECOMBINANT HORMONES OR PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. BIOLOGICS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 21. BIOLOGICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. BIOLOGICS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. BIOLOGICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. BIOLOGICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. CANADA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. CANADA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 49. CANADA BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 50. CANADA BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 51. CANADA BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. CANADA BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. MEXICO BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. MEXICO BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 55. MEXICO BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 56. MEXICO BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 57. MEXICO BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. CHINA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. CHINA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 81. CHINA BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 82. CHINA BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 83. CHINA BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. CHINA BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. INDIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. INDIA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 87. INDIA BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 88. INDIA BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 89. INDIA BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. INDIA BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. JAPAN BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. JAPAN BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 99. JAPAN BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 100. JAPAN BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 101. JAPAN BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. JAPAN BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. SINGAPORE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. THAILAND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. THAILAND BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 135. THAILAND BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 136. THAILAND BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 137. THAILAND BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 138. THAILAND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 152. DENMARK BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. DENMARK BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 154. DENMARK BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 155. DENMARK BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 156. DENMARK BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 157. DENMARK BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. EGYPT BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. EGYPT BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 160. EGYPT BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 161. EGYPT BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 162. EGYPT BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 163. EGYPT BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. FINLAND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. FINLAND BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 166. FINLAND BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 167. FINLAND BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 168. FINLAND BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 169. FINLAND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. FRANCE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. FRANCE BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 172. FRANCE BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 173. FRANCE BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 174. FRANCE BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 175. FRANCE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. GERMANY BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. GERMANY BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 178. GERMANY BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 179. GERMANY BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 180. GERMANY BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. GERMANY BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. ITALY BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. ITALY BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 190. ITALY BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 191. ITALY BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 192. ITALY BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 193. ITALY BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. NORWAY BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 207. NORWAY BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 208. NORWAY BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 209. NORWAY BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 210. NORWAY BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. NORWAY BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. POLAND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. POLAND BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 214. POLAND BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 215. POLAND BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 216. POLAND BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 217. POLAND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. QATAR BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. QATAR BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 220. QATAR BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 221. QATAR BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 222. QATAR BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 223. QATAR BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. SPAIN BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. SPAIN BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 244. SPAIN BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 245. SPAIN BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 246. SPAIN BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 247. SPAIN BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 260. TURKEY BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 261. TURKEY BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 262. TURKEY BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 263. TURKEY BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 264. TURKEY BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 265. TURKEY BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 278. BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 279. BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 280. BIOLOGICS MARKET LICENSE & PRICING